Expert tumor board for hard-to-treat childhood cancers
Part of Cancer clinical trials.
This study brings together a team of experts to review your case and suggest personalized treatment options. It's for children and young adults with cancers that are hard to cure, even with standard treatments, to find new ways to treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer is considered very hard to cure with standard treatments, even if you are newly diagnosed or have had a relapse.
- You are able to do some daily activities on your own (score of 50 or higher on the Karnofsky or Lansky scale).
- You and your doctor are willing to think about new treatment ideas from a special team of experts.
- You agree to let the study team collect your medical records and extra blood samples over time.
- You and your family must understand and sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a treatment plan that uses results from genetic testing of your tumor to choose the best targeted therapy. It may help people whose cancer has come back or does not respond to standard treatment by matching treatment to specific tumor changes.
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
This trial uses information from your tumor’s changes over time to help your care team suggest treatment options. It may help people who are unlikely to be cured with standard treatment by testing new, personalized strategy plans.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This trial tests a new immune therapy using your child's own specially trained white blood cells to fight brain tumors. The treatment is given directly into the fluid around the brain, and it is for children with specific types of brain cancer.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.